Literature DB >> 3572914

Sleep and morning pain in primary osteoarthritis.

H Moldofsky, F A Lue, P Saskin.   

Abstract

Sleep physiology, pain and mood symptoms of 8 patients with idiopathic osteoarthritis of the hands who complained of morning symptoms were compared to 7 age and sex matched subjects with similar joint pathology, but who did not complain of morning symptoms. The "AM Symptoms" group had sleep related (nocturnal) myoclonus, associated with increased morning peripheral joint tenderness and decreased grip strength, whereas the "No Complaint" group had improved mood in the morning.

Entities:  

Mesh:

Year:  1987        PMID: 3572914

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  5 in total

Review 1.  Chronic pain syndromes.

Authors:  S Carette
Journal:  Ann Rheum Dis       Date:  1996-08       Impact factor: 19.103

2.  A pilot study of gentle yoga for sleep disturbance in women with osteoarthritis.

Authors:  Diana M Taibi; Michael V Vitiello
Journal:  Sleep Med       Date:  2011-04-13       Impact factor: 3.492

3.  Hip pain while using lower extremity joints and sleep disturbances in elderly white women: results from a cross-sectional analysis.

Authors:  Neeta Parimi; Terri Blackwell; Katie L Stone; Li-Yung Lui; Sonia Ancoli-Israel; Gregory J Tranah; Teresa A Hillier; Michael E Nevitt; Nancy E Lane
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-07       Impact factor: 4.794

4.  Cognitive behavioral therapy for insomnia improves sleep and decreases pain in older adults with co-morbid insomnia and osteoarthritis.

Authors:  Michael V Vitiello; Bruce Rybarczyk; Michael Von Korff; Edward J Stepanski
Journal:  J Clin Sleep Med       Date:  2009-08-15       Impact factor: 4.062

5.  Initial evaluation of nighttime restlessness in a naturally occurring canine model of osteoarthritis pain.

Authors:  David Knazovicky; Andrea Tomas; Alison Motsinger-Reif; B Duncan X Lascelles
Journal:  PeerJ       Date:  2015-02-17       Impact factor: 2.984

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.